ID: ALA443288

Max Phase: Preclinical

Molecular Formula: C11H12FN5O3

Molecular Weight: 281.25

Molecule Type: Small molecule

Representations

Canonical SMILES:  Nc1nc(F)nc2c1ncn2[C@@H]1C=C(CO)[C@@H](O)[C@H]1O

Standard InChI:  InChI=1S/C11H12FN5O3/c12-11-15-9(13)6-10(16-11)17(3-14-6)5-1-4(2-18)7(19)8(5)20/h1,3,5,7-8,18-20H,2H2,(H2,13,15,16)/t5-,7-,8+/m1/s1

Standard InChI Key:  OZEIJMLOVXLLOD-NJUXHZRNSA-N

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Small molecule

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Properties

Molecular Weight: 281.25

Molecular Weight (Monoisotopic): 281.0924

AlogP: -1.26

#Rotatable Bonds: 2

Polar Surface Area: 130.31

Molecular Species: NEUTRAL

HBA: 8

HBD: 4

#RO5 Violations: 0

HBA (Lipinski): 8

HBD (Lipinski): 5

#RO5 Violations (Lipinski): 0

CX Acidic pKa: 13.08

CX Basic pKa: 0.97

CX LogP: -1.57

CX LogD: -1.57

Aromatic Rings: 2

Heavy Atoms: 20

QED Weighted: 0.40

Np Likeness Score: 0.81

References

1. Obara T, Shuto S, Saito Y, Snoeck R, Andrei G, Balzarini J, De Clercq E, Matsuda A..  (1996)  New neplanocin analogues. 7. Synthesis and antiviral activity of 2-halo derivatives of neplanocin A.,  39  (19): [PMID:8809173] [10.1021/jm960145+]

Source

Source(1):

• Scientific Literature